Advertisement

How DexCom Trounced Wall Street Estimates in Q3

How DexCom Trounced Wall Street Estimates in Q3

DexCom (NASDAQ: DXCM) rebounded quickly from the coronavirus-fueled market meltdown earlier this year. Here are the highlights from DexCom's Q3 update. DexCom reported Q3 revenue of $500.9 million, a 26% increase from the $396.3 million reported in the same quarter of the previous year.